MishraThesis.pdf (4.66 MB)
Download file

Evaluation of prognostic factors for survival in patients with Hepatocellular carcinoma treated with Transarterial Chemoembolisation

Download (4.66 MB)
thesis
posted on 21.05.2020, 00:09 authored by GAURI KAMAL VASENI MISHRA
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the second leading cause of cancer related mortality globally. This is due to the majority of patients presenting at a disease stage not amenable to curative treatments. Transarterial Chemoembolisation (TACE) is the most common treatment for patients with unresectable HCC, however the median survival ranges from 20 to 45 months. Through collaboration with six large Australian tertiary centres and international co-authors this thesis undertakes a comprehensive evaluation of the prognostic factors associated with survival in patients with unresectable HCC undergoing treatment with TACE.

History

Principal supervisor

Stuart Roberts

Additional supervisor 1

Anouk Dev

Year of Award

2020

Department, School or Centre

Central Clinical School

Campus location

Australia

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Medicine, Nursing and Health Sciences